
Victoria Barghout, MSPH
Advertisement
Articles by Victoria Barghout, MSPH
Advertisement
Latest Updated Articles
Tegaserod Treatment for IBS: A Model of Indirect CostsPublished: April 15th 2005 | Updated:
Effectiveness of Tegaserod Therapy on GI-related Resource Utilization in a Managed Care PopulationPublished: April 15th 2005 | Updated:
Total Costs of IBS: Employer and Managed Care PerspectivePublished: April 15th 2005 | Updated:
Budget Impact of Tegaserod on a Managed Care Organization FormularyPublished: April 15th 2005 | Updated:
Impairment in Work Productivity and Health-related Quality of Life in Patients With IBSPublished: April 15th 2005 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5



